(VIANEWS) – Shares of ABL Diagnostics (CAC 40: ABLD.PA) jumped by a staggering 29.41% in 21 sessions from €6.8 to €8.80 at 05:36 EST on Thursday, after five consecutive sessions in a row of losses. CAC 40 is rising 0.11% to €7,326.94, after two sequential sessions in a row of gains.
ABL Diagnostics’s last close was €8.80, 45.27% below its 52-week high of €16.08.
About ABL Diagnostics
ABL Diagnostics Société anonyme does not have significant operations. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Paris, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
Earnings Per Share
As for profitability, ABL Diagnostics has a trailing twelve months EPS of €-0.08.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.12%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ABL Diagnostics’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for ABL Diagnostics is 25 which is 17.58% below its average volume of 91.
Volatility
ABL Diagnostics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.70%, a positive 8.43%, and a positive 15.93%.
ABL Diagnostics’s highest amplitude of average volatility was 1.70% (last week), 9.28% (last month), and 15.93% (last quarter).
Moving Average
ABL Diagnostics’s worth is way higher than its 50-day moving average of €6.68 and way under its 200-day moving average of €11.55.
More news about ABL Diagnostics (ABLD.PA).
